P22307 (NLTP_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 154.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Non-specific lipid-transfer protein Short name=NSL-TP EC=2.3.1.176 Alternative name(s): Propanoyl-CoA C-acyltransferase SCP-chi SCPX Sterol carrier protein 2 Short name=SCP-2 Sterol carrier protein X Short name=SCP-X | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 547 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Mediates in vitro the transfer of all common phospholipids, cholesterol and gangliosides between membranes. May play a role in regulating steroidogenesis. Ref.12 Ref.16 |
| Catalytic activity | 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholanoyl-CoA + propanoyl-CoA = CoA + 3-alpha,7-alpha,12-alpha-trihydroxy-24-oxo-5-beta-cholestanoyl-CoA. |
| Subunit structure | Interacts with PEX5. |
| Subcellular location | Cytoplasm. Mitochondrion. Note: Cytoplasmic in the liver and also associated with mitochondria especially in steroidogenic tissues. Ref.16 Isoform SCPx: Peroxisome. Note: Interaction with PEX5 is essential for peroxisomal import. Ref.16 Isoform SCP2: Mitochondrion Probable Ref.16. |
| Tissue specificity | Liver, fibroblasts, and placenta. |
| Induction | Up-regulated by 4-hydroxy-tamoxifen. Ref.10 |
| Involvement in disease | Leukoencephalopathy, with dystonia and motor neuropathy (LDMN) [MIM:613724]: A syndrome characterized by leukoencephalopathy, dystonic head tremor, spasmodic torticollis and reduced tendon reflexes in lower extremities. Additional features include hyposmia, pathologic saccadic eye movements, a slight hypoacusis, accumulation of branched-chain pristanic acid in plasma, and the presence of abnormal bile alcohol glucuronides in urine. |
| Sequence similarities | In the N-terminal section; belongs to the thiolase family. Contains 1 SCP2 domain. |
| Sequence caution | The sequence AAA03558.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CAV1 | Q03135 | 3 | EBI-1050999,EBI-603614 | |
| Cav1 | P49817 | 3 | EBI-1050999,EBI-1161338 | From a different organism. |
Alternative products
| This entry describes 4 isoforms produced by alternative promoter usage and alternative splicing. [Align] [Select] | ||||||
| Isoform SCPx (identifier: P22307-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform SCP2 (identifier: P22307-2) The sequence of this isoform differs from the canonical sequence as follows: 1-404: Missing. | ||||||
| Note: Contains a mitochondrial transit peptide at positions 1-20 (Potential). | ||||||
| Isoform 3 (identifier: P22307-3) The sequence of this isoform differs from the canonical sequence as follows: 67-110: Missing. 362-547: LAQCAELCWQ...LQLQPGNAKL → GHSCS | ||||||
| Isoform 4 (identifier: P22307-4) The sequence of this isoform differs from the canonical sequence as follows: 1-81: Missing. | ||||||
| Note: Produced by alternative splicing. No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 547 | 547 | Non-specific lipid-transfer protein | PRO_0000034091 | ||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||
| Domain | 433 – 543 | 111 | SCP2 | |||||||||||||||||||||||||||||
| Motif | 545 – 547 | 3 | Microbody targeting signal Potential | |||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||
| Modified residue | 142 | 1 | N6-acetyllysine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 173 | 1 | N6-acetyllysine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 183 | 1 | N6-acetyllysine Ref.13 | |||||||||||||||||||||||||||||
| Modified residue | 282 | 1 | N6-acetyllysine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 341 | 1 | N6-acetyllysine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 425 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 438 | 1 | N6-acetyllysine Ref.13 | |||||||||||||||||||||||||||||
| Modified residue | 453 | 1 | N6-acetyllysine By similarity | |||||||||||||||||||||||||||||
| Modified residue | 470 | 1 | N6-acetyllysine Ref.13 | |||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 404 | 404 | Missing in isoform SCP2. | VSP_018977 | ||||||||||||||||||||||||||||
| Alternative sequence | 1 – 81 | 81 | Missing in isoform 4. | VSP_045187 | ||||||||||||||||||||||||||||
| Alternative sequence | 67 – 110 | 44 | Missing in isoform 3. | VSP_042686 | ||||||||||||||||||||||||||||
| Alternative sequence | 362 – 547 | 186 | LAQCA…GNAKL → GHSCS in isoform 3. | VSP_042687 | ||||||||||||||||||||||||||||
| Natural variant | 155 | 1 | A → D in a breast cancer sample; somatic mutation. Ref.17 | VAR_035706 | ||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||
| Mutagenesis | 528 | 1 | N → D: Strongly reduces sterol carrier and phosphatidylcholine transfer activity; when associated with D-530. Ref.12 | |||||||||||||||||||||||||||||
| Mutagenesis | 528 | 1 | N → I: Strongly reduces sterol carrier and phosphatidylcholine transfer activity. Ref.12 | |||||||||||||||||||||||||||||
| Mutagenesis | 530 | 1 | G → D: Strongly reduces sterol carrier and phosphatidylcholine transfer activity; when associated with D-528. Ref.12 | |||||||||||||||||||||||||||||
| Sequence conflict | 10 | 1 | T → A in AAB41286. Ref.1 | |||||||||||||||||||||||||||||
| Sequence conflict | 393 | 1 | G → D in AAB41286. Ref.1 | |||||||||||||||||||||||||||||
| Sequence conflict | 472 | 1 | A → D in AAB24921. Ref.4 | |||||||||||||||||||||||||||||
| Sequence conflict | 482 | 1 | K → Q in AAB24921. Ref.4 | |||||||||||||||||||||||||||||
| Sequence conflict | 501 | 1 | D → A in AAB24921. Ref.4 | |||||||||||||||||||||||||||||
| Sequence conflict | 522 | 1 | K → P in AAB24921. Ref.4 | |||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||
| Turn | 427 – 430 | 4 | ||||||||||||||||||||||||||||||
| Helix | 432 – 454 | 23 | ||||||||||||||||||||||||||||||
| Beta strand | 457 – 465 | 9 | ||||||||||||||||||||||||||||||
| Helix | 467 – 469 | 3 | ||||||||||||||||||||||||||||||
| Beta strand | 472 – 480 | 9 | ||||||||||||||||||||||||||||||
| Beta strand | 484 – 487 | 4 | ||||||||||||||||||||||||||||||
| Beta strand | 494 – 500 | 7 | ||||||||||||||||||||||||||||||
| Helix | 501 – 508 | 8 | ||||||||||||||||||||||||||||||
| Turn | 509 – 511 | 3 | ||||||||||||||||||||||||||||||
| Helix | 514 – 519 | 6 | ||||||||||||||||||||||||||||||
| Beta strand | 524 – 527 | 4 | ||||||||||||||||||||||||||||||
| Helix | 529 – 533 | 5 | ||||||||||||||||||||||||||||||
| Helix | 534 – 538 | 5 | ||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The structure of the human sterol carrier protein X/sterol carrier protein 2 gene (SCP2)." Ohba T., Rennert H., Pfeifer S.M., He Z., Yamamoto R., Holt J.A., Billheimer J.T., Strauss J.F. III Genomics 24:370-374(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM SCPX). Tissue: Liver. |
| [2] | "cDNAs encoding members of a family of proteins related to human sterol carrier protein 2 and assignment of the gene to human chromosome 1 p21-pter." He Z., Yamamoto R., Furth E.E., Schantz L.J., Naylor S.L., George H., Billheimer J.T., Strauss J.F. III DNA Cell Biol. 10:559-569(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SCPX). Tissue: Liver. |
| [3] | "Cloning and expression of a cDNA encoding human sterol carrier protein 2." Yamamoto R., Kallen C.B., Babalola G.O., Rennert H., Billheimer J.T., Strauss J.F. III Proc. Natl. Acad. Sci. U.S.A. 88:463-467(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SCP2). Tissue: Liver. |
| [4] | "Localization of human sterol carrier protein 2 gene and cDNA expression in COS-7 cell." Yamamoto R. Hokkaido Igaku Zasshi 67:839-848(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SCP2). Tissue: Liver. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). Tissue: Caudate nucleus. |
| [6] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND SCP2). Tissue: Brain. |
| [9] | Bienvenut W.V. Submitted (MAR-2005) to UniProtKB Cited for: PROTEIN SEQUENCE OF 455-462; 512-522 AND 535-546, MASS SPECTROMETRY. Tissue: B-cell lymphoma. |
| [10] | "Regulation of sterol carrier protein gene expression by the forkhead transcription factor FOXO3a." Dansen T.B., Kops G.J., Denis S., Jelluma N., Wanders R.J., Bos J.L., Burgering B.M., Wirtz K.W. J. Lipid Res. 45:81-88(2004) [PubMed] [Europe PMC] [Abstract] Cited for: ALTERNATIVE PROMOTER USAGE, INDUCTION BY 4-HYDROXY-TAMOXIFEN. |
| [11] | "Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy." Ferdinandusse S., Kostopoulos P., Denis S., Rusch H., Overmars H., Dillmann U., Reith W., Haas D., Wanders R.J., Duran M., Marziniak M. Am. J. Hum. Genet. 78:1046-1052(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN LDMN. |
| [12] | "Structure-activity studies of human sterol carrier protein 2." Seedorf U., Scheek S., Engel T., Steif C., Hinz H.-J., Assmann G. J. Biol. Chem. 269:2613-2618(1994) [PubMed] [Europe PMC] [Abstract] Cited for: MUTAGENESIS OF ASN-528 AND GLY-530, FUNCTION. |
| [13] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-183; LYS-438 AND LYS-470, MASS SPECTROMETRY. |
| [14] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [15] | "NMR determination of the secondary structure and the three-dimensional polypeptide backbone fold of the human sterol carrier protein 2." Szyperski T., Scheek S., Johansson J., Assmann G., Seedorf U., Wuethrich K. FEBS Lett. 335:18-26(1993) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF SCP2. |
| [16] | "Recognition of a functional peroxisome type 1 target by the dynamic import receptor Pex5p." Stanley W.A., Filipp F.V., Kursula P., Schueller N., Erdmann R., Schliebs W., Sattler M., Wilmanns M. Mol. Cell 24:653-663(2006) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 426-547 IN COMPLEX WITH PEX5, FUNCTION, SUBCELLULAR LOCATION. |
| [17] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] ASP-155. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U11313 U11312 Genomic DNA. Translation: AAB41286.1.M75883 mRNA. Translation: AAA03557.1. M75884 mRNA. Translation: AAA03558.1. Different initiation. M55421 mRNA. Translation: AAA03559.1. S52450 mRNA. Translation: AAB24921.1. AK295214 mRNA. Translation: BAG58208.1. AL445183, AC099677 Genomic DNA. Translation: CAH72590.1. CH471059 Genomic DNA. Translation: EAX06760.1. CH471059 Genomic DNA. Translation: EAX06761.1. BC005911 mRNA. Translation: AAH05911.1. BC067108 mRNA. Translation: AAH67108.1. | ||||||||||||||||||
| IPI | IPI00026105. IPI00433347. IPI00943320. IPI00977865. | ||||||||||||||||||
| PIR | B40407. I38205. | ||||||||||||||||||
| RefSeq | NP_001007099.1. NM_001007098.2. NP_001007100.1. NM_001007099.2. NP_001007101.1. NM_001007100.2. NP_001007251.1. NM_001007250.2. NP_001180546.1. NM_001193617.1. NP_002970.2. NM_002979.4. | ||||||||||||||||||
| UniGene | Hs.476365. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | P22307. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | P22307. 6 interactions. | ||||||||||||||||||
| STRING | 9606.ENSP00000360569. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P22307. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 2507456. | ||||||||||||||||||
2D gel databases | |||||||||||||||||||
| REPRODUCTION-2DPAGE | IPI00026105. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | P22307. | ||||||||||||||||||
| PRIDE | P22307. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 6342. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000371513; ENSP00000360568; ENSG00000116171. ENST00000371514; ENSP00000360569; ENSG00000116171. ENST00000435345; ENSP00000396413; ENSG00000116171. ENST00000528311; ENSP00000434132; ENSG00000116171. | ||||||||||||||||||
| GeneID | 6342. | ||||||||||||||||||
| KEGG | hsa:6342. | ||||||||||||||||||
| UCSC | uc001cur.2. human. uc001cus.2. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 6342. | ||||||||||||||||||
| GeneCards | GC01P053392. | ||||||||||||||||||
| HGNC | HGNC:10606. SCP2. | ||||||||||||||||||
| HPA | HPA027101. HPA027135. HPA027317. | ||||||||||||||||||
| MIM | 184755. gene. 613724. phenotype. | ||||||||||||||||||
| neXtProt | NX_P22307. | ||||||||||||||||||
| Orphanet | 163684. Leukoencephalopathy - dystonia - motor neuropathy. | ||||||||||||||||||
| PharmGKB | PA35014. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | COG0183. | ||||||||||||||||||
| HOGENOM | HOG000221741. | ||||||||||||||||||
| HOVERGEN | HBG006506. | ||||||||||||||||||
| InParanoid | P22307. | ||||||||||||||||||
| KO | K08764. | ||||||||||||||||||
| OMA | GNAGREH. | ||||||||||||||||||
| OrthoDB | EOG40K7ZM. | ||||||||||||||||||
| PhylomeDB | P22307. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Reactome | REACT_111217. Metabolism. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P22307. | ||||||||||||||||||
| Bgee | P22307. | ||||||||||||||||||
| CleanEx | HS_SCP2. | ||||||||||||||||||
| Genevestigator | P22307. | ||||||||||||||||||
| GermOnline | ENSG00000116171. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 3.40.47.10. 4 hits. | ||||||||||||||||||
| InterPro | IPR003033. SCP2_sterol-bd_dom. IPR016039. Thiolase-like. IPR016038. Thiolase-like_subgr. IPR020615. Thiolase_acyl_enz_int_AS. IPR020617. Thiolase_C. IPR020613. Thiolase_CS. IPR020616. Thiolase_N. [Graphical view] | ||||||||||||||||||
| Pfam | PF02036. SCP2. 1 hit. PF02803. Thiolase_C. 1 hit. PF00108. Thiolase_N. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF55718. SCP2. 1 hit. SSF53901. Thiolase-like. 2 hits. | ||||||||||||||||||
| PROSITE | PS00098. THIOLASE_1. 1 hit. PS00737. THIOLASE_2. 1 hit. PS00099. THIOLASE_3. False negative. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| ChEMBL | CHEMBL5950. | ||||||||||||||||||
| ChiTaRS | SCP2. human. | ||||||||||||||||||
| EvolutionaryTrace | P22307. | ||||||||||||||||||
| GenomeRNAi | 6342. | ||||||||||||||||||
| NextBio | 24628. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | NLTP_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P22307 Secondary accession number(s): B4DHP6 Q99430 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
